BWS
VKTX icon

Buck Wealth Strategies’s Viking Therapeutics VKTX Stock Holding History

Buck Wealth Strategies’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429 Buy
+11
New +$355 ﹤0.01% 1023

Other funds holding VKTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Buck Wealth Strategies's VKTX Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 11 shares worth $429. The stake represents ﹤0.01% of the portfolio and ranks #1023 among its holdings.

206 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Buck Wealth Strategies held 11 shares of Viking Therapeutics worth $429 as of Q2 2026.
  • Viking Therapeutics was a new Buck Wealth Strategies position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1023 holding.
  • 206 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.